April 2015

home / publications / contemporary-oncology / april-2015
When to Consider Referral to a Genetic Counselor for Lesser Known Cancer Syndromes

When to Consider Referral to a Genetic Counselor for Lesser Known Cancer Syndromes

Carmelina E. Heydrich, MS, Katherine A. Schneider, MPH;Huma Q. Rana, MD
April 5th 2015
Article

Experts discuss the clinical features, gene function, and medical management recommendations for six hereditary cancer syndromes.

Maintenance Strategies After Initial Chemotherapy for Non-Small Cell Lung Cancer

Maintenance Strategies After Initial Chemotherapy for Non-Small Cell Lung Cancer

James P. Stevenson, MD
April 1st 2015
Article

James P. Stevenson, MD, discusses optimization of drug and patient selection for maintenance therapies in NSCLC, and how it will continue to be a research focus in today's environment of value-based care.

Funding for the NIH and Lay Communication Regarding Science

Funding for the NIH and Lay Communication Regarding Science

Jason J. Luke, MD, FACP, UPMC Hillman Cancer Center
March 31st 2015
Article

Jason J. Luke, MD, FACP, discusses the stark change in funding priorities by the United States for biomedical research, and the consequences of that.

Antiangiogenesis Agents in Ovarian Cancer

Antiangiogenesis Agents in Ovarian Cancer

BJ Rimel, MD
March 29th 2015
Article

BJ Rimel, MD, discuss the current literature surrounding antiangiogenesis agents in ovarian cancer.

mTOR Biology and the Growing Role for mTOR Inhibitors in the Management of Breast Cancer

mTOR Biology and the Growing Role for mTOR Inhibitors in the Management of Breast Cancer

Elisavet Paplomata, MD;Ruth O’Regan, MD
March 27th 2015
Article

The role of mTOR inhibition in breast cancer is evolving, and ongoing studies are evaluating biomarkers that will identify the patients who will benefit.